https://scholars.lib.ntu.edu.tw/handle/123456789/385431
標題: | Liver cancer cells: Targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres | 作者: | Liao, Y.-T. Liu, C.-H. Yu, J. Wu, K.C.-W. KEVIN CHIA-WEN WU JIASHING YU |
關鍵字: | Alginate; Atomization; Mesoporous silica nanoparticles; Sustained release; Targeting therapy | 公開日期: | 2014 | 卷: | 9 | 期: | 1 | 起(迄)頁: | 2767-2778 | 來源出版物: | International Journal of Nanomedicine | 摘要: | A new microsphere consisting of inorganic mesoporous silica nanoparticles (MSNs) and organic alginate (denoted as MSN@Alg) was successfully synthesized by air-dynamic atomization and applied to the intracellular drug delivery systems (DDS) of liver cancer cells with sustained release and specific targeting properties. MSN@Alg microspheres have the advantages of MSN and alginate, where MSN provides a large surface area for high drug loading and alginate provides excellent biocompatibility and COOH functionality for specific targeting. Rhodamine 6G was used as a model drug, and the sustained release behavior of the rhodamine 6G-loaded MSN@Alg microspheres can be prolonged up to 20 days. For targeting therapy, the anticancer drug doxorubicin was loaded into MSN@Alg microspheres, and the (lysine)4-tyrosine-arginine-glycine-aspartic acid (K4YRGD) peptide was functionalized onto the surface of MSN@Alg for targeting liver cancer cells, hepatocellular carcinoma (HepG2). The results of the 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay and confocal laser scanning microscopy indicate that the MSN@Alg microspheres were successfully uptaken by HepG2 without apparent cytotoxicity. In addition, the intracellular drug delivery efficiency was greatly enhanced (ie, 3.5-fold) for the arginine-glycine-aspartic acid (RGD)-labeled, doxorubicin-loaded MSN@Alg drug delivery system compared with the non-RGD case. The synthesized MSN@Alg microspheres show great potential as drug vehicles with high biocompatibility, sustained release, and targeting features for future intracellular DDS. ? 2014 Liao et al. |
URI: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84901990086&partnerID=MN8TOARS http://scholars.lib.ntu.edu.tw/handle/123456789/385431 |
DOI: | 10.2147/IJN.S60171 | SDG/關鍵字: | alginic acid; arginylglycylaspartic acid; doxorubicin; drug carrier; microsphere; nanoparticle; rhodamine 6G; silicon dioxide; alginic acid; alginic acid; arginyl-glycyl-aspartic acid; delayed release formulation; doxorubicin; glucuronic acid; hexuronic acid; nanocapsule; oligopeptide; silicon dioxide; article; biocompatibility; controlled study; drug targeting; drug uptake; endocytosis; HepG2 cell line; human; human cell; molecularly targeted therapy; surface property; sustained drug release; administration and dosage; animal; chemistry; delayed release formulation; diffusion; HepG2 cell line; Liver Neoplasms, Experimental; metabolism; pathology; porosity; procedures; treatment outcome; Alginates; Animals; Delayed-Action Preparations; Diffusion; Doxorubicin; Glucuronic Acid; Hep G2 Cells; Hexuronic Acids; Humans; Liver Neoplasms, Experimental; Molecular Targeted Therapy; Nanocapsules; Oligopeptides; Porosity; Silicon Dioxide; Treatment Outcome |
顯示於: | 化學工程學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。